Clinical Applications of Magnetic Resonance Spectroscopy in Brain Tumors: From Diagnosis to Treatment

Radiol Clin North Am. 2021 May;59(3):349-362. doi: 10.1016/j.rcl.2021.01.004. Epub 2021 Mar 23.

Abstract

Magnetic resonance spectroscopy (MRS) is a valuable tool for imaging brain tumors, primarily as an adjunct to conventional imaging and clinical presentation. MRS is useful in initial diagnosis of brain tumors, helping differentiate tumors from possible mimics such as metastatic disease, lymphoma, demyelination, and infection, as well as in the subsequent follow-up of patients after resection and chemoradiation. Unfortunately, the spectroscopic appearance of many pathologies can overlap, and ultimately follow-up or biopsy may be required to make a definitive diagnosis. Future developments may continue to increase the value of MRS for initial diagnosis, treatment planning, and early detection of recurrence.

Keywords: Brain tumor; Glioblastoma; Magnetic resonance spectroscopy; Pseudoprogression; Radiation necrosis; Tumor progression.

Publication types

  • Review

MeSH terms

  • Brain / diagnostic imaging
  • Brain Neoplasms / diagnostic imaging*
  • Brain Neoplasms / radiotherapy*
  • Diagnosis, Differential
  • Humans
  • Magnetic Resonance Spectroscopy / methods*